| Phillip Alan Milne, MD | |
|
135 S Wakea Ave Ste 101, Kahului, HI 96732-1385 | |
| (808) 871-8878 | |
| (808) 871-8867 |
| Full Name | Phillip Alan Milne |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Cardiovascular Disease |
| Location | 135 S Wakea Ave Ste 101, Kahului, Hawaii |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710082060 | NPI | - | NPPES |
| 22862-7 | Medicaid | HI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | MD-11315 (Hawaii) | Primary |
| Entity Name | Aloha Cardiology Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467557660 PECOS PAC ID: 2668559881 Enrollment ID: O20080411000217 |
News Archive
A.P. Pharma, Inc., a specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has accepted the Company's resubmission of its New Drug Application (NDA) for APF530.
Meditrina Pharmaceuticals, Inc., a clinical-stage, specialty pharmaceutical company focused on developing and commercializing innovative therapies that treat women's reproductive system disorders, today announced that the United States Patent and Trademark Office (USPTO) has issued a notice of allowance of a patent entitled "Composition Comprising a Combination of an Aromatase Inhibitor, a Progestin, and an Oestrogen and its Use for the Treatment of Endometriosis" to the Company's licensor AstraZeneca.
A new study from researchers at Johns Hopkins Bloomberg School of Public Health found that children treated with stimulants for attention deficit hyperactivity disorder (ADHD) experienced slower body mass index (BMI) growth than their undiagnosed or untreated peers, followed by a rapid rebound of BMI that exceeded that of children with no history of ADHD or stimulant use and that could continue to obesity.
Traditionally, the most commonly used medical devices for spinal fusion procedures have been pedicle screws and rods, and interbody cages or spacers. Each are coupled with bone grafts and limit movement while the area being fused heals.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Phillip Alan Milne, MD 135 S Wakea Ave Ste 101, Kahului, HI 96732-1385 Ph: (808) 871-8878 | Phillip Alan Milne, MD 135 S Wakea Ave Ste 101, Kahului, HI 96732-1385 Ph: (808) 871-8878 |
News Archive
A.P. Pharma, Inc., a specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has accepted the Company's resubmission of its New Drug Application (NDA) for APF530.
Meditrina Pharmaceuticals, Inc., a clinical-stage, specialty pharmaceutical company focused on developing and commercializing innovative therapies that treat women's reproductive system disorders, today announced that the United States Patent and Trademark Office (USPTO) has issued a notice of allowance of a patent entitled "Composition Comprising a Combination of an Aromatase Inhibitor, a Progestin, and an Oestrogen and its Use for the Treatment of Endometriosis" to the Company's licensor AstraZeneca.
A new study from researchers at Johns Hopkins Bloomberg School of Public Health found that children treated with stimulants for attention deficit hyperactivity disorder (ADHD) experienced slower body mass index (BMI) growth than their undiagnosed or untreated peers, followed by a rapid rebound of BMI that exceeded that of children with no history of ADHD or stimulant use and that could continue to obesity.
Traditionally, the most commonly used medical devices for spinal fusion procedures have been pedicle screws and rods, and interbody cages or spacers. Each are coupled with bone grafts and limit movement while the area being fused heals.
› Verified 2 days ago
James E Muto, MD Cardiovascular Disease Medicare: May Accept Medicare Assignments Practice Location: 89 Hookele St, #103, Kahului, HI 96732 Phone: 808-871-8878 Fax: 808-871-8867 | |
Roy M Matsuyama, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 173 Hoohana St, Suite 104, Kahului, HI 96732 Phone: 808-871-7222 Fax: 808-871-2222 | |
Mr. Reginald Glenn Buesa, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 53 S Puunene Ave, Kahului, HI 96732 Phone: 808-877-6020 Fax: 808-873-0617 | |
Dr. Abdiel M Angeles, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 43 Kamehameha Avenue, Kahului, HI 96732 Phone: 808-871-7728 Fax: 808-871-7729 | |
Gerard F. Livaudais, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 39 W Kamehameha Ave, Kahului, HI 96732 Phone: 808-877-2424 | |
Dr. Joanne Godley, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 39 W Kamehameha Ave, Suite B, Kahului, HI 96732 Phone: 808-877-2424 Fax: 808-877-6464 | |
Ryan Fusato, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 110 E Kaahumanu Ave, Kahului, HI 96732 Phone: 808-242-6464 Fax: 808-243-2367 |